Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Retinylamine derivitives for treatment of ocular disorders

Retinylamine derivitives for treatment of ocular disorders

US Patent 10471118 · Granted Nov 12, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for the delivery of nucleic acids2025
Compounds and methods of treating retinal degeneration2025
Compositions and methods for the delivery of nucleic acids2024
Visual cycle modulators2024
Compositions and methods for the delivery of nucleic acids2024
Arctigenin liquid nano-preparation and preparation method thereof2024
Retinylamine derivitives for treatment of ocular disorders2023
Retinylamine derivitives for treatment of ocular disorders2023
Compounds and methods of treating retinal degeneration2023
Molecular probes and methods of use2023
Compositions and methods for the delivery of nucleic acids2022
Visual cycle modulators2022